Guided Therapeutics Receives $70,000 -- Its Second of Nine Payments Totaling $700,000 -- from New Chinese Distribution Partner that Provides Products for 2 Million Annual Cervical Cancer Screenings
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTC:QB GTHP), the maker of the LuViva Advanced Cervical Scan, announced that on August 14th 2025, it had received a payment of $7...
How does this funding round compare to recent capital raises by peer companies in the cervical cancer screening space, and what implications might it have for the stock valuation?
What revenue growth can be expected from the new Chinese distribution partnership for the LuViva Advanced Cervical Scan?
How will the $70,000 payment and the remaining scheduled payments affect Guided Therapeutics' cash position and runway?
6 days ago